The 66th Annual Meeting of the American Society of Hematology (ASH) in 2024 will be held on December 7-10 in San Diego, USA. As one of the world's largest, most comprehensive, and most highly regarded international academic events in the field of hematology, the ASH Annual Meeting will invite hematologists and related healthcare professionals from more than 100 countries around the globe to gather together, announce the top research abstracts in the field of hematology, and share and discuss the world's cutting-edge research advances and groundbreaking clinical research results as well as invaluable clinical practice experiences.

As a witness and participant in the rapid development of the global hematology field, GoBroad Medical team has reported China's research results for more than a hundred times in international conferences such as EHA, ASH, EBMT, ASCO, and so on. In this year's ASH Annual Meeting, GoBroad medical team will present 17 research results, including 2 oral speeches, 11 poster presentations, and 4 abstracts, ranging from optimizing hematopoietic stem cell transplantation strategies to improve the prognosis of patients with relapsed and refractory hematological diseases, to exploring the frontiers of CAR-T to bring more hope to patients with relapsed and refractory hematological diseases; from targeting gene mutations to guide clinical decision-making in hematologic diseases to filling the gaps in genetic profiles of Chinese children's lymphomas, GoBroad once again shares China's innovative achievements with the world, escorting the lives of more patients with hematologic diseases.